27.06.2012 - China Pharmaceutical Group said it would buy pharmaceutical assets from its parent company for HK$8.98 billion ($1.16 billion) as it aims to expand its finished drug business and...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)